Ferreri AJ.Risk of CNS dissemination in extranodal lymphomas[J].Lancet Oncol,2014,15(4):e159-e169.
[2]
Luz E,Marques M,Luz I,et al.Survival and prognostic factors for AIDS and non-AIDS patients with non-Hodgkin’s lymphoma in Bahia,Brazil:a retrospective cohort study[J].ISRN Hematology,2013,105(16):1 224-1 229.
Zhang YX,Gui XE,Zhong YH,et al.Cancer in cohort of HIV-infected population:prevalence and clinical characteristics[J].J Cancer Res Clin Oncol,2011,137(4):609-614.
[5]
孙开宇,桂希恩,张永喜,等.53例艾滋病相关非霍奇金淋巴瘤患者的临床特征及预后分析[J].中华血液学杂志,2017,38(2):97-101.Sun KY,Gui XE,Zhang YX.Clinic pathological features and survival of patients with AIDS related nonHodgkin’s lymphoma[J].Chin J Hematol,2017,38(2):97-101.
[6]
Gotti D,Raffetti E,Albini L,et al.Survival in HIVInfected Patients after a Cancer Diagnosis in the cART Era:results of an Italian Multicenter Study[J].PLoS One,2014,9(4):e94768.
[7]
Cobucci RN,Lima PH,de Souza PC.Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS:a systematic review[J].J Infect Public Health,2015,8(1):1-10.
[8]
Achenbach CJ,Buchanan AL,Cole SR,et al.HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy[J].Clin Infect Dis,2014,58(11):1 599-1 606.
